In the project below, custom made sequencing panels are being used to profile ctDNA.
These panels have been designed by the OMDC and tailored in strong partnership with specialists and suppliers of molecular detection products:
Dr. Jenny Taylor, Wellcome Centre for Human Genetics
Mutation profiling of circulating tumour DNA to inform prognosis and treatment selection for head and neck cancers
Dr Beth Psaila, NDCLS, Prof. Tim Maughan, Dept. of Oncology
Development of a novel targeted panel for the sequencing of ctDNA in solid tumour cancer patients. (ArcherDx)
Dr. Graham Collins, Dept. of Oncology
Detection of circulating DNA tumour in newly diagnosed Hodgkin lymphoma patients